Work

Targeting 14-3-3 Sensitizes Native and Mutant BCR-ABL to Inhibition with U0126, Rapamycin and Bcl-2 Inhibitor GX15-070.

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.2920.2920

Authors: Shaozhong Dong, Sumin Kang, Sagar Lonial, Hanna Jean Khoury, Jean Viallet, Jing Chen

Institutions: Emory University, Winship Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2595138906

FWCI:

Cites:

Cited by:

Related to: 10